Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
First Solar
FSLR
|
+$24.3M |
| 2 |
Lamb Weston
LW
|
+$21.6M |
| 3 |
Ovintiv
OVV
|
+$21.3M |
| 4 |
Hubbell
HUBB
|
+$21.3M |
| 5 |
U-Haul Holding Co Series N
UHAL.B
|
+$19.6M |
Top Sells
| 1 |
Apple
AAPL
|
+$627M |
| 2 |
Microsoft
MSFT
|
+$479M |
| 3 |
Amazon
AMZN
|
+$203M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$169M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$150M |
Sector Composition
| 1 | Technology | 25.32% |
| 2 | Healthcare | 16.62% |
| 3 | Consumer Discretionary | 10.98% |
| 4 | Industrials | 9.74% |
| 5 | Consumer Staples | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1451
NMI Holdings
NMIH
$3.08B
| $4.05M | ﹤0.01% |
193,874
| – | – |
|
1452
Parsons
PSN
$8.18B
| $4.05M | ﹤0.01% |
87,500
+1,400
| +2% | +$64.8K |
|
1453
Certara
CERT
$1.81B
| $4.03M | ﹤0.01% |
251,000
+4,600
| +2% | +$73.9K |
|
1454
Celldex Therapeutics
CLDX
$1.62B
| $4.02M | ﹤0.01% |
90,300
+2,100
| +2% | +$93.6K |
|
1455
Northwest Natural Holdings
NWN
$1.73B
| $4M | ﹤0.01% |
84,000
+2,800
| +3% | +$133K |
|
1456
Urban Edge Properties
UE
$2.66B
| $3.99M | ﹤0.01% |
283,509
+5,100
| +2% | +$71.9K |
|
1457
Trupanion
TRUP
$1.87B
| $3.97M | ﹤0.01% |
83,610
+1,500
| +2% | +$71.3K |
|
|
GRP.U
1458
Granite Real Estate Investment Trust
GRP.U
$3.43B
| $3.97M | ﹤0.01% |
77,800
+1,000
| +1% | +$51K |
|
1459
StoneX
SNEX
$5.04B
| $3.96M | ﹤0.01% |
93,600
+2,025
| +2% | +$85.8K |
|
1460
TG Therapeutics
TGTX
$5.1B
| $3.94M | ﹤0.01% |
333,200
+7,800
| +2% | +$92.3K |
|
1461
Methode Electronics
MEI
$287M
| $3.94M | ﹤0.01% |
88,700
+900
| +1% | +$39.9K |
|
|
EVOP
1462
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $3.92M | ﹤0.01% |
115,700
+2,300
| +2% | +$77.8K |
|
1463
SiTime
SITM
$6.76B
| $3.91M | ﹤0.01% |
38,500
+1,100
| +3% | +$112K |
|
|
VRTV
1464
DELISTED
VERITIV CORPORATION
VRTV
| $3.89M | ﹤0.01% |
32,000
-1,100
| -3% | -$134K |
|
1465
Akero Therapeutics
AKRO
$3.48B
| $3.89M | ﹤0.01% |
71,000
+1,800
| +3% | +$98.6K |
|
1466
Phreesia
PHR
$1.45B
| $3.88M | ﹤0.01% |
119,800
+2,300
| +2% | +$74.4K |
|
1467
Frontline
FRO
$5.17B
| $3.88M | ﹤0.01% |
324,254
+32,104
| +11% | +$384K |
|
1468
Adtalem Global Education
ATGE
$4.94B
| $3.87M | ﹤0.01% |
109,100
+2,100
| +2% | +$74.6K |
|
1469
Maravai LifeSciences
MRVI
$386M
| $3.86M | ﹤0.01% |
270,000
+4,900
| +2% | +$70.1K |
|
1470
Worthington Enterprises
WOR
$3.17B
| $3.86M | ﹤0.01% |
126,029
+648
| +0.5% | +$19.9K |
|
1471
Addus HomeCare
ADUS
$2.03B
| $3.86M | ﹤0.01% |
38,800
+700
| +2% | +$69.6K |
|
1472
InvenTrust Properties
IVT
$2.33B
| $3.85M | ﹤0.01% |
162,800
+3,000
| +2% | +$71K |
|
|
RCM
1473
DELISTED
R1 RCM Inc. Common Stock
RCM
| $3.85M | ﹤0.01% |
351,600
+20,000
| +6% | +$219K |
|
1474
MillerKnoll
MLKN
$1.4B
| $3.85M | ﹤0.01% |
183,152
+3,400
| +2% | +$71.4K |
|
1475
AAR Corp
AIR
$2.67B
| $3.84M | ﹤0.01% |
85,500
+1,900
| +2% | +$85.3K |
|